Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Golvatinib |
Trade Name | |
Synonyms | E7050|E-7050 |
Drug Descriptions |
Golvatinib (E7050) is a dual kinase inhibitor of c-Met (MET) and KDR (VEGFR2), which inhibits cell growth and proliferation (PMID: 25458359, PMID: 25278451). |
DrugClasses | EPHB4 Inhibitor 6 MET Inhibitor 59 VEGFR2 Inhibitor 37 |
CAS Registry Number | 928037-13-2 |
NCIT ID | C82363 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gefitinib + Golvatinib | Gefitinib Golvatinib | 0 | 0 |
Golvatinib | Golvatinib | 0 | 1 |